semaglutide vomiting law office in michigan gastrointestinal obstruction GLP-1s are a hot topic for diabetes treatment at Medscape | Novo Nordisk has

Ohio's GLP-1 coverage fractured in 2025-2026 State of Ohio employee plan, OSU Health Plan, and Ohio Medicaid all narrowed weight-loss GLP-1 access

Eligibility for a GLP-1 medication depends on a Service Members diagnosis, prior authorization, and/or medical necessity.Service Members who are overweight with other risk factors or obese should work with their Department of War (DoW) medical officer or Primary Care Manager/Provider to determine if a GLP-1 medication is appropriate before starting these medications.The use of GLP-1 medications during training, deployments, or operational platforms might not be authorized

While they are often discussed in the context of weight loss, their origins (and their impact) are rooted in deeper biological systems that regulate appetite, blood sugar, and energy balance

Semaglutide is a GLP-1 receptor agonist that is used to treat diabetes and obesity

Novo Nordisk launches a $199 introductory offer for Wegovy and Ozempic and lowers ongoing self-pay prices, expanding access and countering compounded semaglutide risks.

Forbes expert healthcare contributors explain the growing cyclosporiasis outbreak, how the parasite spreads, symptoms to watch for and how you can protect yourself.